RARA CRAFT DATABASE for FDA Medical Devices
510(k)K231972

FDA DEVICE FACTS

Advanta VXT Vascular Graft, Flixene Vascular Graft

Atrium Medical Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 28, 2024PRODUCT CODEDSY

Indications for use

Environment Surgical Suite Same as Predicate Intended User/Operator They are intended to be implanted by surgeons trained in the theoretical, technical and clinical aspects of vascular reconstruction, bypass and creation of arteriovenous vascular access.Other potential users include dialysis-related nursing staff and clinicians trained in generic vascular access use. Same as Predicate Intended Patient Population Advanta VXT and Flixene vascular grafts are intended for use in adult patients. Same as Predicate Intended Use Advanta VXT and Flixenevascular grafts are intended for use in the replacementor repair of peripheral arteries, and for use as an arteriovenous shunt for vascular access. Same as Predicate Atrium Medical Corporation Premarket Notification Traditional 510(k) Advanta VXT Vascular Graft Flixene Vascular Graft

Figure 1 Vascular Graft Example

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 17, 2026